MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $685,220 | -7.8% | 4,692 | +45.8% | 0.01% | -22.2% |
| Q2 2023 | $743,589 | +23825.0% | 3,219 | -74.9% | 0.01% | -81.2% |
| Q1 2023 | $3,108 | +26.8% | 12,829 | +51.9% | 0.05% | 0.0% |
| Q4 2022 | $2,451 | -99.5% | 8,445 | +7.9% | 0.05% | +336.4% |
| Q3 2022 | $509,000 | -9.1% | 7,828 | +0.1% | 0.01% | -26.7% |
| Q2 2022 | $560,000 | -22.5% | 7,817 | -8.4% | 0.02% | +25.0% |
| Q4 2021 | $723,000 | +42.0% | 8,536 | +52.7% | 0.01% | -47.8% |
| Q4 2019 | $509,000 | – | 5,589 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |